Wyeth
Wyeth is one of the world’s leading pharmaceutical and healthcare products companies with a major focus on developing innovative new medicines.
At a Glance
Company in Ireland
University Research
Wyeth Pharmaceuticals is a Key Strategic Client of IDA. Headquartered in, Madison, New Jersey, it is a research based global pharmaceutical company employing 51,400 people worldwide. It has thirty seven manufacturing facilities in seventeen countries. In 2008 Wyeth had sales of $22.8 billion and net earnings of $4.4 billion. R&D expenditure in the year was $3.37 billion.
Wyeth produces pharmaceuticals, consumer healthcare products, veterinary medicines and nutritional products. Pharmaceutical sales including nutritionals and veterinary medicines, but excluding OTC, represent 85% of sales.
Wyeth has four production and development operations in Ireland employing over 3000 people. Wyeth is the biggest employer and largest single investor in the pharmaceutical industry in Ireland.
The operations are as follows:
Wyeth Nutritionals Ireland established at Askeaton, Co. Limerick in 1974 employs 660 in the manufacture of infant nutritional products. Because the primary raw material is milk, this project is dealt with by Enterprise Ireland.
Fort Dodge Laboratories Ireland Limited was established in Sligo in 1990 and it employs 100 people in the manufacture of small and large animal vaccines.
Wyeth Medica Ireland (WMI) was established in Newbridge in 1992. It employs 1,300 people in the manufacture of ethical pharmaceuticals and it is one of the largest solid dosage plants in Europe.
Wyeth Biopharma at Grangecastle represents a €1.8 billion investment. It manufactures a range of recombinant biopharmaceutical products and human vaccines. It currently employs 1,300.
Programme:
SFI Investigator Clusters.
Institutions:
University College Dublin (Conway Institute)
Project:
Irish Centre for Applied Neurotherapeutics. The centre identifies unique brain mechanisms amenable to the development of new and more effective drugs for the treatment of mental illness.
Researcher:
The lead investigator is Prof. Ciaran Regan.
Programme:
SFI Investigator.
Institution:
Dublin City University.
Project:
Understanding and exploiting gene expression profiles of cultivated animal cells in order to develop improved biopharmaceutical production processes.
Researcher:
Prof. Martin Clynes.
On January 26th 2009 Pfizer and Wyeth announced that they have entered into a definitive merger agreement. The total transaction is valued at approximately $68 billion.
Other Case Studies
Funded by the Irish Government under the National Development Plan 2007-2013
© IDA Ireland 2010
© IDA Ireland 2010
